PRESS RELEASE published on 03/25/2025 at 15:00, 10 months 27 days ago Appointment of Joint Corporate Broker easyJet plc appoints Panmure Liberum as Joint Corporate Broker, working alongside BNP Paribas BNP Paribas Appointment EasyJet Plc Joint Corporate Broker Panmure Liberum
PRESS RELEASE published on 03/25/2025 at 14:59, 10 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group PLC The Vanguard Group, Inc. discloses a 1.60% stake in Bakkavor Group plc according to Form 8.3 under the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure Bakkavor Group
PRESS RELEASE published on 03/25/2025 at 14:58, 10 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Aviva PLC The Vanguard Group, Inc. discloses a 5.10% ownership in Aviva PLC. Additional disclosure includes dealings with Direct Line Insurance Group plc. Form 8.3 filing on 25 March 2025 Form 8.3 Vanguard Group Ownership Disclosure Direct Line Insurance Aviva Plc
PRESS RELEASE published on 03/25/2025 at 14:56, 10 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Assura PLC The Vanguard Group, Inc. discloses ownership of 5.61% stake in Assura PLC. Dealing disclosure includes purchases and sales of 10p ordinary shares Sales The Vanguard Group Ownership Disclosure Purchases Assura Plc
PRESS RELEASE published on 03/25/2025 at 14:55, 10 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group PLC The Vanguard Group, Inc. discloses 3.33% ownership in Dalata Hotel Group PLC as of 24 March 2025. Purchase and sale of $0.01 ordinary shares disclosed The Vanguard Group Inc. Ownership Disclosure Dalata Hotel Group Plc Purchase And Sale $0.01 Ordinary Shares
PRESS RELEASE published on 03/25/2025 at 14:53, 10 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings Inc The Vanguard Group, Inc. discloses an 11.79% ownership in American Axle & Manufacturing Holdings Inc. through form 8.3 submission Form 8.3 Vanguard Group Ownership Disclosure Financial Disclosure American Axle
PRESS RELEASE published on 03/25/2025 at 14:49, 10 months 27 days ago EQS-Adhoc: Vulcan Energy Resources Limited: Vulcan awarded EU Strategic Project status under Critical Raw Materials Act Vulcan Energy Resources Limited awarded EU Strategic Project status under Critical Raw Materials Act, securing sustainable supply chain for lithium in Europe Vulcan Energy Resources Limited European Commission Sustainable Supply Chain Critical Raw Materials Act EU Strategic Project Status
PRESS RELEASE published on 03/25/2025 at 14:28, 10 months 27 days ago Athena Bitcoin's Chief Compliance Officer to Speak at FIBA's 2025 AML Conference Athena Bitcoin's Chief Compliance Officer, Sam Nazzaro, to Speak at FIBA's 2025 AML Conference on March 25, 2025 in Miami, discussing crypto compliance challenges and regulatory landscapes Chief Compliance Officer Athena Bitcoin FIBA Crypto Compliance AML Conference
PRESS RELEASE published on 03/25/2025 at 14:15, 10 months 27 days ago EQS-Adhoc: Leifheit Aktiengesellschaft: Leifheit AG proposes an increased ordinary dividend and a special dividend for the financial year 2024 Leifheit Aktiengesellschaft proposes increased ordinary and special dividend for financial year 2024 in line with dividend policy Special Dividend Dividend Financial Year 2024 Leifheit Aktiengesellschaft Proposal
Published on 02/21/2026 at 00:45, 1 day 2 hours ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 day 3 hours ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 1 day 4 hours ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 day 5 hours ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/21/2026 at 12:00, 15 hours 36 minutes ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 15 hours 36 minutes ago Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 1 day 9 hours ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 day 9 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 19:29, 1 day 8 hours ago SFPI GROUP: bilan du contrat de liquidité S2 S025
